Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statin Therapy Reduces the Mycobacterium tuberculosis Burden in Human Macrophages and in Mice by Enhancing Autophagy and Phagosome Maturation
Suraj P. Parihar, Reto Guler, Rethabile Khutlang, et al.
The Journal of Infectious Diseases (2013) Vol. 209, Iss. 5, pp. 754-763
Open Access | Times Cited: 274

Showing 1-25 of 274 citing articles:

Host-directed therapies for bacterial and viral infections
Stefan H. E. Kaufmann, Anca Dorhoi, Richard S. Hotchkiss, et al.
Nature Reviews Drug Discovery (2017) Vol. 17, Iss. 1, pp. 35-56
Open Access | Times Cited: 617
Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling
Autumn G. York, Kevin J. Williams, Joseph P. Argus, et al.
Cell (2015) Vol. 163, Iss. 7, pp. 1716-1729
Open Access | Times Cited: 384
Immune evasion and provocation by Mycobacterium tuberculosis
Pallavi Chandra, Steven J. Grigsby, Jennifer A. Philips
Nature Reviews Microbiology (2022) Vol. 20, Iss. 12, pp. 750-766
Open Access | Times Cited: 322
Development of autophagy inducers in clinical medicine
Beth Levine, Milton Packer, Patrice Codogno
Journal of Clinical Investigation (2015) Vol. 125, Iss. 1, pp. 14-24
Open Access | Times Cited: 310
Host-directed therapies for infectious diseases: current status, recent progress, and future prospects
Alimuddin Zumla, Martin Rao, Robert S. Wallis, et al.
The Lancet Infectious Diseases (2016) Vol. 16, Iss. 4, pp. e47-e63
Open Access | Times Cited: 306
Advancing host-directed therapy for tuberculosis
Robert S. Wallis, Richard Hafner
Nature reviews. Immunology (2015) Vol. 15, Iss. 4, pp. 255-263
Closed Access | Times Cited: 271
Membrane Microdomain Disassembly Inhibits MRSA Antibiotic Resistance
Esther García‐Fernández, Gudrun Koch, Rabea M. Wagner, et al.
Cell (2017) Vol. 171, Iss. 6, pp. 1354-1367.e20
Open Access | Times Cited: 225
The Macrophage: A Disputed Fortress in the Battle against Mycobacterium tuberculosis
Christophe J. Queval, Roland Brosch, Roxane Siméone
Frontiers in Microbiology (2017) Vol. 8
Open Access | Times Cited: 201
Therapeutic targeting of autophagy in neurodegenerative and infectious diseases
David C. Rubinsztein, Carla F. Bento, Vojo Deretić
The Journal of Experimental Medicine (2015) Vol. 212, Iss. 7, pp. 979-990
Open Access | Times Cited: 188
Drug Repurposing for the Treatment of Bacterial and Fungal Infections
Andrea Miró-Canturri, Rafael Ayerbe-Algaba, Younes Smani
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 188
Diabetes and Tuberculosis
Blanca I. Restrepo
Microbiology Spectrum (2016) Vol. 4, Iss. 6
Open Access | Times Cited: 175
Therapeutic host-directed strategies to improve outcome in tuberculosis
Carly Young, Gerhard Walzl, Nelita du Plessis
Mucosal Immunology (2019) Vol. 13, Iss. 2, pp. 190-204
Open Access | Times Cited: 164
Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management
Dale Liebenberg, Bhavna G. Gordhan, Bavesh D Kana
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 85
Signaling pathways in macrophages: molecular mechanisms and therapeutic targets
Ming Li, Mengjie Wang, Yuanjia Wen, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 49
Inducible antibacterial responses in macrophages
Matthew J. Sweet, Divya Ramnath, Amit Singhal, et al.
Nature reviews. Immunology (2024) Vol. 25, Iss. 2, pp. 92-107
Closed Access | Times Cited: 17
Tuberculosis vaccines and therapeutic drug: challenges and future directions
Yajing An, Ruizi Ni, Zhuang Li, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access | Times Cited: 4
Macrophage Autophagy and Bacterial Infections
Aïcha Bah, Isabelle Vergne
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 149
Therapeutic Targeting of Autophagy
Amabel M. Orogo, Åsa B. Gustafsson
Circulation Research (2015) Vol. 116, Iss. 3, pp. 489-503
Open Access | Times Cited: 141
Bacterial Pathogens versus Autophagy: Implications for Therapeutic Interventions
Jacqueline M. Kimmey, Christina L. Stallings
Trends in Molecular Medicine (2016) Vol. 22, Iss. 12, pp. 1060-1076
Open Access | Times Cited: 141
Current and Emerging Uses of Statins in Clinical Therapeutics: A Review
Jonathan Tokonjay Davies, Spencer Delfino, Chad E. Feinberg, et al.
Lipid Insights (2016) Vol. 9
Open Access | Times Cited: 138
Statins: a viable candidate for host-directed therapy against infectious diseases
Suraj P. Parihar, Reto Guler, Frank Brombacher
Nature reviews. Immunology (2018) Vol. 19, Iss. 2, pp. 104-117
Open Access | Times Cited: 126
Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent
Shankar Thangamani, Haroon Mohammad, Mostafa F. N. Abushahba, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 125
Host-Directed Therapeutic Strategies for Tuberculosis
Afsal Kolloli, Selvakumar Subbian
Frontiers in Medicine (2017) Vol. 4
Open Access | Times Cited: 124
Is There Potential for Repurposing Statins as Novel Antimicrobials?
Emma Hennessy, Claire Adams, F. Jerry Reen, et al.
Antimicrobial Agents and Chemotherapy (2016) Vol. 60, Iss. 9, pp. 5111-5121
Open Access | Times Cited: 123
Chewing the fat: lipid metabolism and homeostasis during M. tuberculosis infection
Rustin R. Lovewell, Christopher M. Sassetti, Brian C. VanderVen
Current Opinion in Microbiology (2015) Vol. 29, pp. 30-36
Closed Access | Times Cited: 113
Page 1 - Next Page

Scroll to top